Merck (MRK) Tax Provisions (2009 - 2026)

Merck (MRK) has 18 years of Tax Provisions data on file, last reported at $709.0 million in Q1 2026.

• Tax Provisions for Q1 2026 came in at $709.0 million, down 13.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 billion (down 0.81% YoY), and the FY2025 annual result was $2.8 billion, changed 0.04% from the prior year.
• Tax Provisions grew to $709.0 million in Q1 2026 per MRK's latest filing, from $458.0 million in the prior quarter.
• Over five years, Tax Provisions peaked at $958.0 million in Q3 2025 and troughed at -$820.0 million in Q4 2023.
• A 5-year average of $573.3 million and a median of $571.0 million in 2025 frame the typical range for Tax Provisions.
• The sharpest annual moves came in 2022 and 2023: Tax Provisions surged 482.35% in 2022, then slumped 265.66% in 2023.
• A 5-year view of Tax Provisions shows it stood at $495.0 million in 2022, then tumbled by 265.66% to -$820.0 million in 2023, then surged by 151.95% to $426.0 million in 2024, then climbed by 7.51% to $458.0 million in 2025, then soared by 54.8% to $709.0 million in 2026.
• Business Quant data shows MRK's Tax Provisions at $709.0 million in Q1 2026, $458.0 million in Q4 2025, and $958.0 million in Q3 2025.